Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIMENSION: Vitamin D Supplementation in T2DM
NCT01741181Phase 4Completed
- Sponsor
- Tan Tock Seng Hospital
- Start
- Sep 2012
- Primary completion
- Nov 2014
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Vitamin D deficiency (VDD) comparing Vitamin D supplementation with Placebo pill (2 arms). Primary endpoints: Endothelial function as assessed by the reactive hyperemia index at 16 weeks and Endothelial progenitor cells count at 16 weeks. Started Sep 2012; status: completed.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT01741181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01741181.